Jafron Biomedical Co.,Ltd. (SHE:300529)
China · Delayed Price · Currency is CNY 14.97
-0.25 (-1.64%)
Sep 11, 2026, 3:04 PM CST
Jafron Biomedical Market Cap
Jafron Biomedical has a market cap or net worth of 11.59 billion as of September 11, 2026. Its market cap has decreased by -37.31% in one year.
Market Cap
11.59B
Enterprise Value
10.45B
Revenue
1.91B
Ranking
n/a
PE Ratio
22.24
Stock Price
14.97
ChartMarket Cap Chart
Since August 2, 2016, Jafron Biomedical's market cap has increased from 6.41B to 11.59B, an increase of 80.94%. That is a compound annual growth rate of 6.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 11.59B | -23.89% |
| Dec 31, 2025 | 15.23B | -32.96% |
| Dec 31, 2024 | 22.72B | 27.96% |
| Dec 29, 2023 | 17.76B | -28.23% |
| Dec 30, 2022 | 24.74B | -42.00% |
| Dec 31, 2021 | 42.65B | -21.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Double Medical Technology | 15.65B |
| Shandong Weigao Blood Purification Products | 13.00B |
| MeHow Innovative | 12.45B |
| Insight Lifetech | 12.18B |
| Cofoe Medical Technology | 11.33B |
| Shanghai MicroPort Endovascular MedTech | 10.26B |
| Qingdao NovelBeam Technology | 9.68B |
| Qingdao Haier Biomedical Co.,Ltd | 9.64B |